Measures of bioavailable serum testosterone and estradiol and their relationships with muscle mass, muscle strength and bone mineral density in postmenopausal women: A cross-sectional study

European Journal of Endocrinology

Volumn 160, Issue 4, 2009, Pages 681-687

  Van Geel, Tineke A C M ^b   Geusen, Piet P ^a   Winkens, Bjorn ^b   Sels, Jean Pierre J E ^a   Dinant, Geert Jan ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; DEOXYPYRIDINOLINE; ESTRADIOL; OSTEOCALCIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; HORMONE;

ADULT; AGE; AGED; ARTICLE; BIOAVAILABILITY; BONE DENSITY; CREATININE URINE LEVEL; ESTRADIOL BLOOD LEVEL; FEMALE; FEMUR NECK; GRIP STRENGTH; HUMAN; HUMAN EXPERIMENT; LEAN BODY WEIGHT; MUSCLE MASS; MUSCLE STRENGTH; NORMAL HUMAN; OSTEOLYSIS; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN DETERMINATION; QUADRICEPS FEMORIS MUSCLE; SEX HORMONE DETERMINATION; SPINE; TESTOSTERONE BLOOD LEVEL; AGING; BLOOD; BODY COMPOSITION; BODY MASS; CROSS-SECTIONAL STUDY; HAND STRENGTH; HISTOLOGY; METABOLISM; MIDDLE AGED; ORGAN SIZE; PHYSIOLOGY; QUALITY CONTROL; SKELETAL MUSCLE;

AGED; AGING; BODY COMPOSITION; BODY MASS INDEX; BONE DENSITY; CROSS-SECTIONAL STUDIES; ESTRADIOL; FEMALE; HAND STRENGTH; HORMONES; HUMANS; MIDDLE AGED; MUSCLE STRENGTH; MUSCLE, SKELETAL; ORGAN SIZE; POSTMENOPAUSE; QUALITY CONTROL; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 64549094688     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0702     Document Type: Article

References (34)

1. Beld van den AW, Jong de FH, Grobbee DE, Pols HA & Lamberts SW. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. Journal of Clinical Endocrinology and Metabolism 2000 85 3276-3282.
2. Khosla S & Riggs BL. Pathophysiology of age-related bone loss and osteoporosis. Endocrinology and Metabolism Clinics of North America 2005 34 1015-1030 (xi).
3. Greendale GA, Edelstein S & Barrett Connor E. Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo Study. Journal of Bone and Mineral Research 1997 12 1833-1843.
4. Khosla S, Melton LJ III, Atkinson EJ, O'Fallon WM, Klee GG & Riggs BL. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. Journal of Clinical Endocrinology and Metabolism 1998 83 2266-2274.
5. Vanderschueren D, Vandenput L, Boonen S, Lindberg MK, Bouillon R & Ohlsson C. Androgens and bone. Endocrine Reviews 2004 25 389-425.
6. Lufkin EG, Wahner HW, O'Fallon WM, Hodgson SF, Kotowicz MA, Lane AW, Judd HL, Caplan RH & Riggs BL. Treatment of postmenopausal osteoporosis with transdermal estrogen. Annals of Internal Medicine 1992 117 1-9.
7. Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh L, Lenrow DA, Holmes JH, Dlewati A, Santanna J, Rosen CJ & Strom BL. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. Journal of Clinical Endocrinology and Metabolism 1999 84 2647-2653.
8. Herbst KL & Bhasin S. Testosterone action on skeletal muscle. Current Opinion in Clinical Nutrition and Metabolic Care 2004 7 271-277.
9. Bhasin S, Calof OM, Storer TW, Lee ML, Mazer NA, Jasuja R, Montori VM, Gao W & Dalton JT. Drug insight: testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging. Nature Clinical Practice. Endocrinology & Metabolism 2006 2 146-159.
10. Chen J, Kim J & Dalton JT. Discovery and therapeutic promise of selective androgen receptor modulators. Molecular Interventions 2005 5 173-188.
11. Ferrando AA, Sheffield Moore M, Yeckel CW, Gilkison C, Jiang J, Achacosa A, Lieberman SA, Tipton K, Wolfe RR & Urban RJ. Testosterone administration to oldermen improvesmuscle function: molecular and physiological mechanisms. American Journal of Physiology. Endocrinology and Metabolism 2002 282 E601-E607.
12. Cappola AR, Ratcliffe SJ, Bhasin S, Blackman MR, Cauley J, Robbins J, Zmuda JM, Harris T & Fried LP. Determinants of serum total and free testosterone levels inwomen over the age of 65 years. Journal of Clinical Endocrinology and Metabolism 2007 92 509-516.
13. Hakkinen K & Pakarinen A. Muscle strength and serum testosterone, cortisol and SHBG concentrations in middle-aged and elderly men and women. Acta Physiologica Scandinavica 1993 148 199-207.
14. Padero MC, Bhasin S & Friedman TC. Androgen supplementation in older women: too much hype, not enough data. Journal of the American Geriatrics Society 2002 50 1131-1140.
15. Sands R & Studd J. Exogenous androgens in postmenopausal women. American Journal of Medicine 1995 98 76s-79s.
16. Pardridge WM. Serum bioavailability of sex steroid hormones. Clinics in Endocrinology and Metabolism 1986 15 259-278.
17. Vermeulen A, Verdonck L & Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. Journal of Clinical Endocrinology and Metabolism 1999 84 3666-3672.
18. Voort van der DJM, Geusens PP & Dinant GJ. Risk factors for osteoporosis related to their outcome: fractures. Osteoporosis International 2001 12 630-638.
19. Podsiadlo D & Richardson S. The timed 'Up & Go': a test of basic functional mobility for frail elderly persons. Journal of the American Geriatrics Society 1991 39 142-148.
20. Andree G, Bachani B, Pregger K, Durham AP & El Shami AS. Use of an extended NCCLS EP5 Protocol to characterize the precision and sensitivity of the IMMULITE 2000 total testosterone assay. Clinical Chemistry 2004 50 A100.
21. Field A. Discovering Statistics Using SPSS for Windows Trowbridge: The Cromwell Press Ltd, 2000.
22. Anonymous. Coat a Count - estradiol. Siemens Medical Solutions Diagnostics, 2006.
23. Anonymous. Coat a Count - total testosterone. Siemens Medical Solutions Diagnostics, 2006.
24. Gower BA & Nyman L. Associations among oral estrogen use, free testosterone concentration, and lean body mass among post-menopausal women. Journal of Clinical Endocrinology and Metabolism 2000 85 4476-4480.
25. Morley JE, Baumgartner RN, Roubenoff R, Mayer J & Nair KS. Sarcopenia. Journal of Laboratory and Clinical Medicine 2001 137 231-243.
26. Lynch NA, Metter EJ, Lindle RS, Fozard JL, Tobin JD, Roy TA, Fleg JL & Hurley BF. Muscle quality. I. Age-associated differences between arm and leg muscle groups. Journal of Applied Physiology 1999 86 188-194.
27. Yu Z, Dadgar N, Albertelli M, Gruis K, Jordan C, Robins DM & Lieberman AP. Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model. Journal of Clinical Investigation 2006 116 2663-2672.
28. Cauley JA, Black DM, Barrett Connor E, Harris F, Shields K, Applegate W & Cummings SR. Effects of hormone replacement therapy on clinical fractures and height loss: the Heart and Estrogen/Progestin Replacement Study (HERS). American Journal of Medicine 2001 110 442-450.
29. Nevitt MC, Cummings SR, Stone KL, Palermo L, Black DM, Bauer DC, Genant HK, Hochberg MC, Ensrud KE, Hillier TA & Cauley JA. Risk factors for a first-incident radiographic vertebral fracture in women > or =65 years of age: the study of osteoporotic fractures. Journal of Bone and Mineral Research 2005 20 131-140.
30. Garnero P & Delmas PD. Bone markers. Baillière's Clinical Rheumatology 1997 11 517-537.
31. Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H, Muller C, Cormier C, Breart G, Meunier PJ & Delmas PD. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study. Journal of Bone and Mineral Research 1996 11 1531-1538.
32. Wilson EM. Muscle-bound? A tissue-selective nonsteroidal androgen receptor modulator Endocrinology 2007 148 1-3.
33. LeBoff MS, Hawkes WG, Glowacki J, Yu Yahiro J, Hurwitz S & Magaziner J. Vitamin D-deficiency and post-fracture changes in lower extremity function and falls in women with hip fractures. Osteoporosis International 2008 19 1283-1290.
34. Faulkner KA, Cauley JA, Zmuda JM, Landsittel DP, Newman AB, Studenski SA, Redfern MS, Ensrud KE, Fink HA, Lane NE & Nevitt MC. Higher 1,25-dihydroxyvitamin D3 concentrations associated with lower fall rates in older community-dwelling women. Osteoporosis International 2006 17 1318-1328.